Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Gareth Morgan, MD
PeerBetsy O'Donnell, MD
PeerBetsy O'Donnell, MD
PeerOptimizing the Screening of Precursor Diseases in Multiple Myeloma
Betsy O'Donnell, MD
PeerRichard T. Penson, MD, MRCP
PeerThe Evolving Landscape of Endometrial Cancer Treatments
Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
Helping Ensure Adequate Tissue Sampling Within the MDT
Managing Patients Within a Multidisciplinary Team Approach
Pre-Testing: Working Together Toward Testing
Interpreting Test Results and Making the Treatment Decision Within the MDT
Advocate for the Pathologist Within the MDT